Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone

Ítems similars

• Effectiveness of Switching from Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres
  per: Covell, Nancy H, et al.
  Publicat: (2012)
• Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons
  per: Ascher-Svanum, Haya, et al.
  Publicat: (2012)
• A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
  per: Ascher-Svanum, Haya, et al.
  Publicat: (2004)
• Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
  per: Ascher-Svanum, Haya, et al.
  Publicat: (2014)
• Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
  per: Marcus, Steven C., et al.
  Publicat: (2008)